awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26766715-DE8ED142-C695-419A-BD63-F8F7F0EA81E2
Q26766715-DE8ED142-C695-419A-BD63-F8F7F0EA81E2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26766715-DE8ED142-C695-419A-BD63-F8F7F0EA81E2
Engineered IgG1-Fc--one fragment to bind them all
P2860
Q26766715-DE8ED142-C695-419A-BD63-F8F7F0EA81E2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26766715-DE8ED142-C695-419A-BD63-F8F7F0EA81E2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
971170548885d00fc1b4fb0d81990b1a4858f724
P2860
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial